Abiopharma

News list

Director DeVore Susan D. 🟡 adjusted position in 0 shares (1 derivative) of Solventum Corp (SOLV) Transaction Date: Apr 30, 2026 | Filing ID: 000004

Full text

News bot May 1, 2026, 8:27 p.m.
🔍 DeVore Susan D. (Director)

Company: Solventum Corp (SOLV)

Report Date: 2026-04-30
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 3,403
- Total shares sold: 3,403
Detailed Transactions and Holdings:
- Acquired 3,403 shares of Common Stock (Direct)
  Date: 2026-04-30 | Code: M | equity_swap_involved: 0 | shares_owned_after: 8,947.00 | transaction_form_type: 4
- Sold 3,403 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-30 | Code: M | Expires: 2035-04-30 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
- F1: Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement.
- F2: The RSUs are fully vested.